| Date Filed | Type | Description |
| 05/08/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 05/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/28/2023 |
SC 13G/A
| Sessa Capital , L.P. reports a 0% stake in PROVENTION BIO, INC. |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/27/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/27/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/26/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/26/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/19/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/05/2023 |
SC 13G/A
| Sessa Capital , L.P. reports a 17.8% stake in PROVENTION BIO, INC. |
| 03/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/24/2023 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 03/24/2023 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 03/24/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data |
| 03/17/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/13/2023 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 03/13/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/13/2023 |
8-K
| Amended existing or entered into new employment agreement with an officer, Appointed a new director|
Docs:
|
"Execution Version AGREEMENT AND PLAN OF MERGER among SANOFI S.A., ZEST ACQUISITION SUB, INC. and PROVENTION BIO, INC. Dated as of March 12, 2023",
"AMENDED AND RESTATED BYLAWS OF PROVENTION BIO, INC.",
"SECOND AMENDMENT TO FIRST AMENDED EMPLOYMENT AGREEMENT",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT",
"SECOND AMENDMENT TO FIRST AMENDED EMPLOYMENT AGREEMENT",
"Sandrine Guendoul" |
|
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 1.3% stake in Provention Bio, Inc. |
|